The Neurocognitive Sub-study of Encore1

NCT01516060 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

71

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV

Interventions

DRUG: Efavirenz
DRUG: Efavirenz

Sponsor

Kirby Institute

Collaborators

[object Object]